Showing 35,508 results

Neurological & cognitive problems

HIV in the brain: new tools and treatment to keep your mind beautiful

News
25 February 2016
Starting treatment

Removing clinic barriers to rapid initiation of ART in Uganda enables 70% to start on the same day

News
25 February 2016
Finance & funding

Support people with HIV: STOP THE CUTS

Editor's pick
Stop HIV Cuts
25 February 2016
HIV treatment for children & young people

Dolutegravir safe and highly effective in older children

News
25 February 2016
Injectable & long-acting PrEP

Long-acting PrEP injection tolerable and acceptable for male volunteers, but dose adjustment needed

News
25 February 2016
PrEP science

Tenofovir alafenamide PrEP protects monkeys from infection, but rectal and vaginal levels in humans may be too low

News
25 February 2016
New & experimental HIV treatments

TAF/emtricitabine maintains viral suppression as well as TDF regimens with less bone and kidney toxicity

News
25 February 2016
PrEP

What is a drug “tail,” and what does it have to do with long-acting PrEP?

Editor's pick
BETA blog
25 February 2016
How HIV works

Bacteria in our gut affects HIV—is there a solution?

Editor's pick
BETA blog
25 February 2016
Hepatitis C treatment

New recommendations in the updated WHO guidelines for the screening, care and treatment of persons with chronic hepatitis C infection

Editor's pick
World Health Organization
25 February 2016
Chemsex & recreational drug use

Club Drug Use Among Lesbian, Gay, Bisexual and Trans (LGBT) People

Editor's pick
NEPTUNE
25 February 2016
UK health services

UK: HIV support services face closure as councils withdraw funding

Editor's pick
The Independent
25 February 2016
Global health targets

PopART trial shows feasibility of reaching 90-90-90 targets for testing and treatment coverage in Zambia and South Africa

News
25 February 2016
Global health targets

Botswana close to reaching the 90-90-90 testing and treatment targets

News
25 February 2016
Pregnancy and vertical transmission

Cotrimoxazole prophylaxis provides no benefit for HIV-exposed uninfected children

News
25 February 2016
HIV testing programmes & uptake

Partner notification feasible and effective in African settings

News
25 February 2016
Men who have sex with men (MSM)

Very high levels of chemsex and ‘slamsex’ seen in HIV-positive men attending English/Welsh HIV clinics

News
24 February 2016
Vaginal rings & topical PrEP

More investment needed in developing female-controlled HIV prevention options

Editor's pick
UNAIDS
24 February 2016
Pregnancy and vertical transmission

Option B+ cuts mother-to-child HIV transmission dramatically in Malawi

News
24 February 2016
Men who have sex with men (MSM)

Nigerian government must scale up fight against HIV

Editor's pick
Key Correspondents
24 February 2016
Human rights

HIV and TB link the Bronx and Tugela Ferry in a story of human rights and social justice

Editor's pick
Science Speaks
24 February 2016
Human rights

Russia Proposes Dedicated Health Facilities To Treat Homosexuality And Pedophilia

Editor's pick
Sexuality Policy Watch
24 February 2016
Starting treatment

Starting HIV treatment at first clinic visit improves outcomes in African study

News
24 February 2016
New & experimental HIV treatments

Gilead announces results from first study to evaluate switching to FTAF-based regimens from Truvada® (FTDF)-based regimens

Editor's pick
Gilead press release
24 February 2016